LIXT logo

LIXT Stock Overview

Profile

Full Name:

Lixte Biotechnology Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 25, 2007

Indexes:

Not included

Website:

http://lixte.com

Description:

Lixte Biotechnology Holdings is a company focused on developing new cancer treatments. They create innovative drugs that target cancer cells while minimizing harm to healthy cells. Their research aims to improve cancer therapy and provide better options for patients facing this disease.

Key Details

Price

$1.32

Market Cap

$2.97 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$2.66(+33.33% YoY)

PE Ratio

-

Annual ROE

-127.34%

Annual Debt To Equity

0.00

Beta

0.24

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 5, 2023

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with LIXT included

US stocks
Stocks below SMA 200
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Stocks with low beta
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.32
LIXT price is $1.32

Price All-time High

$58.70
LIXT price is currently -97.75% below its historical high of $58.70

Price Analysts Target

-
LIXT price consensus analysts' forecast is unknown

Price Most Recent Change

+5.6%
LIXT price was up +5.6% on Feb 24, 2025

Price YTD Change

-34.98%
LIXT price is down -34.98% since January 1st

Price 3-Year Change

-91.2%
LIXT price is down -91.2% over the past 3 years

Market cap

Market Cap

$2.97 M
LIXT market capitalization is $2.97 million

Market Cap 3-Year Change

-85.6%
LIXT market capitalization is down -85.6% over the past 3 years

Market Cap All-time High

$69.05 M
LIXT market capitalization is currently -95.70% below its historical high of $69.05 million

Market Cap Sector Rank

8.54%
LIXT market capitalization is higher than 8.54% of companies in Healthcare sector

Technical

Beta

0.24
LIXT beta is 0.24

200-day SMA

$2.11
LIXT price is currently -37.50% below its 200-day simple moving average

14-day RSI

30.83
LIXT 14-day relative strength index is 30.83

30-day Relative Volume

0.30
LIXT 30-day relative volume is 0.30

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
LIXT annual revenue value is unknown

Annual Revenue Analysts Estimate

-
LIXT annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
LIXT annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
LIXT annual revenue is unknown

Profit

Annual Gross Profit

-
LIXT annual gross profit value is unknown

Annual Gross Margin

-
LIXT annual gross profit margin value is unknown

Annual Operating Profit

-$5.09 M
LIXT annual operating income is -$5.09 million

Annual Operating Margin

-
LIXT annual operating profit margin value is unknown

Annual Net Income

-$5.09 M
LIXT annual net profit is -$5.09 million

Annual Net Margin

-
LIXT annual net profit margin value is unknown

EPS

Annual EPS

-$2.66
LIXT annual earnings per share is -$2.66

Annual EPS Analysts Estimate

-
LIXT annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+33.33%
LIXT annual earnings per share is up +33.33% year-on-year

Annual EPS Sector Rank

36.28%
LIXT annual earnings per share is higher than 36.28% of companies in Healthcare sector

ROA & ROE

Annual ROA

-118.07%
LIXT annual return on assets is -118.07%

Annual ROE

-127.34%
LIXT annual return on equity is -127.34%

EBIT & EBITDA

Annual EBIT

-$5.07 M
LIXT annual earnings before interest & taxes is -$5.07 million

Annual EBITDA

-$5.07 M
LIXT annual EBITDA is -$5.07 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
LIXT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
LIXT price to earnings ratio is unknown

PB Ratio

PB Ratio

-1.39
LIXT price to book ratio is -1.39

PB Ratio Sector Rank

8.28%
LIXT price to book ratio is higher than 8.28% of companies in Healthcare sector

PS Ratio

PS Ratio

-
LIXT price to sales ratio value is unknown

PS Ratio Sector Rank

-
LIXT price to sales ratio is unknown

Enterprise value

Enterprise Value

$1.33 M
LIXT enterprise value is $1.33 million

Enterprise Value Sector Rank

12.95%
LIXT enterprise value is higher than 12.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.33
LIXT EV/EBITDA is -0.33

EV/EBITDA Sector Rank

58.93%
LIXT EV/EBITDA is higher than 58.93% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

13.73
LIXT annual current ratio is 13.73

Annual Quick Ratio

-
LIXT annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
LIXT annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-313.01
LIXT annual interest coverage ratio is -313.01

Risk & Stability

Piotroski F-Score

-
LIXT piotroski f-score value is unknown

Altman Z-Score

-
LIXT altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$4.31 M
LIXT annual total assets is $4.31 million

Annual Non Current Assets

$0.00
LIXT annual long term assets is $0.00

Annual Current Assets

$4.31 M
LIXT annual total current assets is $4.31 million

Annual Cash & Cash Equivalents

$4.20 M
LIXT annual cash & cash equivalents is $4.20 million

Equity

Annual Book Value

$494.80 K
LIXT annual book value is $494.80 thousand

Annual Working Capital

$3.99 M
LIXT annual working capital is $3.99 million

Liabilities

Annual Total Liabilities

$313.90 K
LIXT annual total liabilities is $313.90 thousand

Annual Total Long Term Liabilities

$0.00
LIXT annual total long term liabilities is $0.00

Annual Current Liabilities

$313.90 K
LIXT annual total current liabilities is $313.90 thousand

Annual Accounts Payable

$120.50 K
LIXT annual accounts payable is $120.50 thousand

Debt

Annual Total Debt

$0.00
LIXT annual total debt is $0.00

Annual Total Debt 1-Year Change

0%
LIXT {parameterFullLabel} has remained unchanged year-on-year

Annual Long Term Debt

-
LIXT annual long term debt value is unknown

Annual Short Term Debt

-
LIXT annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$5.09 M
LIXT annual total expenses is $5.09 million

Annual Operating Expenses

$5.09 M
LIXT annual total operating expenses is $5.09 million

Annual Cost Of Goods Sold

-
LIXT annual cost of goods sold value is unknown

Annual SGA

$4.19 M
LIXT annual SGA is $4.19 million

Annual D&A

-
LIXT annual depreciation & amortization value is unknown

Annual Interest Expense

$16.20 K
LIXT annual interest expense is $16.20 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$4.29 M
LIXT annual cash flow from operations is -$4.29 million

Annual CFO 1-Year Change

+6.9%
LIXT annual cash flow from operations is up +6.9% year-on-year

Annual CFI

-
LIXT annual cash flow from investing activities value is unknown

Annual CFI 1-Year Change

-
LIXT annual cash flow from investing activities 1-year change is unknown

Annual CFF

$3.14 M
LIXT annual cash flow from financing activities is $3.14 million

Annual CFF 1-Year Change

-38.86%
LIXT annual cash flow from financing activities is down -38.86% year-on-year

Free CashFlow

Annual FCF

-$4.29 M
LIXT annual free cash flow is -$4.29 million

Annual FCF 1-Year Change

+6.9%
LIXT annual free cash flow is up +6.9% year-on-year

CAPEX

Annual CAPEX

-
LIXT annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
LIXT annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

TTOO logo
T2 Biosystems (TTOO)
NBY logo
NovaBay Pharmaceuticals (NBY)
HSDT logo
Helius Medical Technologies (HSDT)
PALI logo
Palisade Bio (PALI)
Scinai Immunotherapeutics (SCNI)
WINT logo
Windtree Therapeutics (WINT)
APTO logo
Aptose Biosciences (APTO)
Azitra (AZTR)
TTNP logo
Titan Pharmaceuticals (TTNP)

FAQ

  • What is the ticker symbol for Lixte Biotechnology Holdings?
  • Does Lixte Biotechnology Holdings pay dividends?
  • What sector is Lixte Biotechnology Holdings in?
  • What industry is Lixte Biotechnology Holdings in?
  • What country is Lixte Biotechnology Holdings based in?
  • When did Lixte Biotechnology Holdings go public?
  • Is Lixte Biotechnology Holdings in the S&P 500?
  • Is Lixte Biotechnology Holdings in the NASDAQ 100?
  • Is Lixte Biotechnology Holdings in the Dow Jones?
  • When was Lixte Biotechnology Holdings's last earnings report?
  • When does Lixte Biotechnology Holdings report earnings?

What is the ticker symbol for Lixte Biotechnology Holdings?

The ticker symbol for Lixte Biotechnology Holdings is NASDAQ:LIXT

Does Lixte Biotechnology Holdings pay dividends?

No, Lixte Biotechnology Holdings does not pay dividends

What sector is Lixte Biotechnology Holdings in?

Lixte Biotechnology Holdings is in the Healthcare sector

What industry is Lixte Biotechnology Holdings in?

Lixte Biotechnology Holdings is in the Biotechnology industry

What country is Lixte Biotechnology Holdings based in?

Lixte Biotechnology Holdings is headquartered in United States

When did Lixte Biotechnology Holdings go public?

Lixte Biotechnology Holdings's initial public offering (IPO) was on October 25, 2007

Is Lixte Biotechnology Holdings in the S&P 500?

No, Lixte Biotechnology Holdings is not included in the S&P 500 index

Is Lixte Biotechnology Holdings in the NASDAQ 100?

No, Lixte Biotechnology Holdings is not included in the NASDAQ 100 index

Is Lixte Biotechnology Holdings in the Dow Jones?

No, Lixte Biotechnology Holdings is not included in the Dow Jones index

When was Lixte Biotechnology Holdings's last earnings report?

Lixte Biotechnology Holdings's most recent earnings report was on Nov 12, 2024

When does Lixte Biotechnology Holdings report earnings?

The next expected earnings date for Lixte Biotechnology Holdings is May 9, 2025